PI Publications
- 2022Clinical Audit of Survival Outcomes and Prognostic Factors in Adolescents and Adults with Medulloblastoma. Journal of Adolescent and Young Adult Oncology.11(1):68-77. PMID: 33891492
Patil R, Gupta T, Maitre M, Dasgupta A, Sahay A, Epari S, Shirsat N, Chatterjee A, Krishnatry R, Goda JS, Moiyadi A, Patil V, Chinnaswamy G, Bano N, Jalali R
Post-cricoid and Upper Oesophagus Cancers Treated with Organ Preservation Using Intensity-modulated Image-guided Radiotherapy: A Phase II Prospective Study of Outcomes, Toxicity and Quality of Life. Clinical Oncology (R Coll Radiol).34(4):220-229. PMID: 34872822Laskar SG, Sinha S, Singh M, Mummudi N, Mittal R, Gavarraju A, Budrukkar A, Swain M, Agarwal JP, Gupta T, Murthy V, Mokal S, Patil V, Noronha V, Joshi A, Menon N, Prabhash K
Endolymphatic sac tumor: single-institution series of seven cases with updated review of literature. European Archives of Oto-Rhino-Laryngology. 279(5):2591-2598.PMID: 34410472Talukdar R, Epari S, Sahay A, Choudhari A, Dasgupta A, Chatterjee A, Gupta T
Hydroxychloroquine in the treatment of coronavirus disease 2019: Rapid updated systematic review and meta-analysis. Reviews in Medical Virology. 32(2): e2276. PMID: 34245622Gupta T, Thakkar P, Kalra B, Kannan S
Radiation-Induced Meningioma in a Case of Medulloblastoma Treated 11 Years Ago-Detected on 68Ga-DOTANOC PET/CT. Clinical Nuclear Medicine. 1;47(1): e108-e110. PMID: 34183498Dev ID, Puranik AD, Rangarajan V, Gupta T, Purandare NC, Agrawal A, Shah S
Systematic review and meta-analysis of randomized controlled trials comparing elective neck dissection versus sentinel lymph node biopsy in early-stage clinically node-negative oral and/or oropharyngeal squamous cell carcinoma: Evidence-base for practice and implications for research. Oral Oncology. 124: 105642. PMID: 34861565Gupta T, Maheshwari G, Kannan S, Nair S, Chaturvedi P, Agarwal J
Prognostic impact of semantic MRI features on survival outcomes in molecularly subtyped medulloblastoma. Strahlentherapie und Onkologie. 198(3):291-303. PMID: 35059761Dasgupta A, Gupta T, Maitre M, Kalra B, Chatterjee A, Krishnatry R, Goda JS, Shirsat N, Epari S, Sahay A, Janu A, Pungavkar S, Chinnaswamy G, Patil V, Moiyadi A, Shetty P, Jalali R.
Optimizing post-operative adjuvant therapy in elderly patients with newly-diagnosed glioblastoma: Single-institution audit of clinical outcomes from a tertiary-care comprehensive cancer centre in India. World Neurosurgery. 161: e587-e595. PMID: 35192971Chatterjee A, Bhadane M, Manjali JJ, Dasgupta A, Epari S, Sahay A, Patil V, Moiyadi A, Shetty P, Gupta T
Compliance of radiotherapy treatment at a tertiary cancer center in India—A clinical audit. Indian Journal of Medical and Paediatric Oncology. 43(1): 84-91.Khanna N, Kumar A, Sehra N, Ghosh -Laskar S, Mummudi N, Gupta T, Tibdewal A, Pathak R, Wadasadawala T, Krishnatry R, Chopra S, Goda J, Chatterjee A, Budrukkar A, Gurram L, Engineer R, Murthy V, Swain M, Laskar S, Sarin R, Agarwal J
Neuro-cognitive function and survival in children with average-risk medulloblastoma treated with hyperfractionated radiation therapy alone: long-term mature outcomes of a prospective study. Neuro-Oncology Practice.9(3):236-245.PMID: 35601967Gupta T, Kalra B, Goswami S, Deodhar J, Rane P, Epari S, Moidadi A, Dasgupta A, Chatterjee A, Chinnaswamy G
Should Sentinel Lymph Node Biopsy Be Considered the New Standard of Care for Early-Stage Clinically Node-Negative Oral Squamous Cell Carcinoma? Journal of Clinical Oncology. 40(15):1706-1709. PMID: 3529829Gupta T, Maheshwari G, Kannan S, Nair S, Agarwal JP
Impact of immobilisation and image guidance protocol on planning target volume margins for supine craniospinal irradiation. Reports of Practical Oncology and Radiotherapy.27(2):250-259 PMID: 36299390Krishnatry R, Gudi S, Siwach A, Patil A, Rajesh KR, Shekhar H, Sutar V, Chatterjee A, Goda J, Jalali R, Gupta T
Definitive and adjuvant radiation therapy for external auditory canal and temporal bone squamous cell carcinomas: Long term outcomes. Radiotherapy Oncology. 170: 151–158. PMID: 35219800Laskar SG, Sinha S, Pai DP, Nair D, Budrukkar A, Swain M, Kimar A, Moiyadi A, Shetty P, Roy V, Johnny C, Murthy V, Gupta T, Menon N, Patil V, Noronha V, Joshi A, Prabhash K, Agarwal JP
Systemic inflammatory biomarkers in primary central nervous system lymphoma versus high-grade glioma: exploratory, comparative and correlative analysis. CNS Oncology. 11(2): CNS83. PMID: 35373582Gupta T, Nayak P, Baviskar Y, Gupta M, Moiyadi A, Epari S, Janu A, Purandare N, Rangarajan V, Bagal B, Chatterjee A, Sastri GJ
Concurrent cetuximab-based bioradiotherapy versus cisplatin-based chemoradiotherapy in the definitive management of favourable biology human papillomavirus-associated oropharyngeal squamous cell carcinoma: systematic review and meta-analysis. Clinical Oncology (R Coll Radiol) 34:786-795.PMID: 35387752Swain M, Kannan S, Srinivasan S, Agarwal JP, Gupta T
Machine-learning approach to predict molecular subgroups of medulloblastoma using multiparametric MRI-based tumor radiomics. British Journal of Radiology. 23:20211359. PMID: 35262407.Saju AC, Chatterjee A, Sahu A, Gupta T, Krishnatry R, Mokal S, Sahay A, Epari S, Prasad M, Chinnaswamy G, Agarwal JP, Goda JS
The promise of magnetic resonance imaging in radiation oncology practice in the management of brain, prostate, and GI malignancies. JCO Global Oncology. 8: e2100366 PMID: 35609219Srinivasan S, Dasgupta A, Chatterjee A, Baheti A, Engineer R, Gupta T, Murthy V
Mebendazole plus lomustine or temozolomide in patients with recurrent glioblastoma: A randomised open-label phase II trial. eClinicalMedicine. 49: 101449.PMID: 35747192Patil V, Menon N, Chatterjee A, Tonse R, Choudhari A, Mahajan A, Puranik A, Epari S, Jadhav M, Pathak S, Peelay Z, Walavalkar R, Muthuluri H, Krishna M, Chandrasekharan A, Pande N, Gupta T, Banvali S, Jalali R
Omission of upfront craniospinal irradiation in patients with low-risk WNT-pathway medulloblastoma is associated with unacceptably high risk of neuraxial failure. Clinical Cancer Research. 28(19):4180-4185. PMID: 35653134Gupta T, Pervez S, Dasgupta A, Chatterjee A, Epari S, Chinnaswamy G, Jalali R
Compliance with Radiotherapy Treatment in an Apex Cancer Center of India. JCO Global Oncology. 8: e2100201. PMID: 34985910Khanna N, Ghosh Laskar S, Gupta T, Agarwal JP
Tackling brain metastases from lung cancer during the COVID-19 pandemic. Cancer Reports. 5: e1276. PMID: 32881412Mummudi N, Tibdewal A, Gupta T, Patil V, Prabhash K, Agarwal JP
High-dose salvage re-irradiation in recurrent/progressive adult diffuse gliomas: development of a novel prognostic scoring system. Cancer Radiotherapy. 26(8):994-1001.PMID: 35715356Maitre M, Gupta T, Maitre P, Chatterjee A, Dasgupta A, Moiyadi A, Shetty P, Epari S, Sahay A, Patil V, Krishnatry R, Goda J, Jalali R
Impact of the first Wave of COVID-19 pandemic on radiotherapy practice at Tata Memorial Centre, Mumbai: A longitudinal cohort study. JCO Global Oncology. 8: e2100365. PMID: 35802835.Tibdewal A, Pathak R, Kumar A, Anand S, Ghosh Laskar S, Sarin R, Chopra S, Engineer R, Laskar S, Murthy V, Gupta T, Agarwal JP
Concurrent chemoradiotherapy with cisplatin given once-a-week versus every-three weekly in head and neck squamous cell carcinoma: Non-inferior, equivalent, or superior? Oral Oncology. 134: 106130. PMID: 36162191Gupta T, Kannan S, Ghosh-Laskar S, Agarwal JP
- 2021Pilot testing and vernacular translation of a questionnaire for assessment of satisfaction in patients on radiotherapy in India. Indian Journal of Cancer. 58(4): 573-582. PMID: 33402589
Manjali JJ, Gupta T, Ghosh-Laskar S, Jalali R, Sarin R, Agarwal JP
Brain FET PET tumor-to-white mater ratio to differentiate recurrence from post-treatment changes in high-grade gliomas. Journal of Neuroimaging. 31(6):1211-1218. PMID: 34388273Puranik AD, Rangarajan V, Dev ID, Jain Y, Purandare NC, Sahu A, Choudhary A, Gupta T, Chatterjee A, Moiyadi A, Shetty P, Sridhar E, Sahay A, Patil VM, Shah S, Agrawal A
Atypical Teratoid/Rhabdoid Tumor: Revisiting Histomorphology and Immunohistochemistry with Analysis of Cyclin D1 Overexpression and MYC Amplification. International Journal of Surgical Pathology. 29(2):155-164. PMID: 32703045Sali AP, Epari S, Nagaraj TS, Sahay A, Chinnaswamy G, Shetty P, Moiyadi A, Gupta T
TERT promoter mutation in adult glioblastomas: It's correlation with other relevant molecular markers. Neurology India. 69:126-34. PMID: 33642283Barange M, Epari S, Gurav M, Shetty O, Sahay A, Shetty P, Goda J, Moiyadi A, Gupta T, Jalali R
Primary intracranial Ewing sarcoma/ peripheral primitive neuroectodermal tumor, an entity of unacquaintance: a series of 8 cases. Child's Nervous System. 37(3):839-849. PMID: 32761378Deshpande G, Epari S, Gupta C, Shetty O, Gurav M, Chinnaswamy G, Gupta T
Safety and efficacy of concurrent carboplatin during full-dose craniospinal irradiation for high-risk/metastatic medulloblastoma in a resource-limited setting. Pediatric Blood & Cancer: e28925. PMID: 33533557Gupta T, Sinha, S, Chinnaswamy G, Vora T, Prasad M, Bhat V, Goda JS, Krishnatry R, Chatterjee A, Epari S, Sahay A, Moiyadi A, Shetty P, Patil V, Khatua S, Jalali R, Kurkure P
High-dose salvage re-irradiation for recurrent/progressive adult diffuse glioma: healing or hurting? Clinical and Translational Oncology. 23(7):1358-1367. PMID: 33528810Gupta T, Maitre M, Maitre P, Goda JS, Krishnatry R, Chatterjee A, Moiyadi A, Shetty P, Epari S, Sahay A, Patil V, Jalali R
Clinical approach to re-irradiation for recurrent diffuse intrinsic pontine glioma. Japanese Journal of Clinical Oncology. 51(5): 762-768. PMID: 33521824Krishnatry R, Manjali JJ, Chinnaswamy G, Chatterjee A, Goda JS, Janu A, Sahu A, Jalali R, Gupta T
Distress Screening in Head and Neck Cancer Patients Planned for Cancer-Directed Radiotherapy. Laryngoscope. 131(9):2023-2029. PMID: 33720420Lewis S, Pandey S, Salins N, Deodhar J, Patil V, Gupta T, Laskar SG, Budrukkar A, Murthy V, Joshi A, Prabhash K, Nair S, Chaturvedi P, Noronha V, Agarwal JP
An analysis of the factors associated with long term survival in patients with glioblastoma. World Neurosurgery. 149: e758-e765. PMID: 33540096Madhugiri V, Moiyadi AV, Shetty P, Gupta T, Epari S, Jalali R, Subeikshanan V, Dutt A, Sasidharan G, Kumar V, Ganesh C V Ramesh A, Prabhu A
Prospective longitudinal assessment of quality of life. and activities of daily living as patient-reported outcome measures in recurrent/progressive glioma treated with high-dose salvage re-irradiation. Clinical Oncology (R Coll Radiol). 33(3): e155-e165. PMID: 32917486Maitre P, Gupta T, Maitre M, Goda J, Krishnatry R, Chatterjee A, Sridhar E, Sahay A, Mokal S, Moiyadi A, Shetty P, Patil V, Jalali R
The proteomic analysis shows enrichment of RNA surveillance pathways in adult SHH and extensive metabolic reprogramming in Group 3 medulloblastomas. Brain Tumor Pathology. 38(2):96-108. PMID: 33438046Manubhai Kp, Kumar A, Biswas D, Moiyadi A, Shetty P, Gupta T, Epari S, Shirsat N, Srivastava S
Clinico-radiological characteristics, histo-pathological features and long-term survival outcomes in central neurocytoma: A single-institutional audit. Journal of Clinical Neurosciecne. 84:91-96. PMID: 33358093Pawar D, Chatterjee A, Epari S, Sahay A, Janu A, Krishantry R, Goda JS, Shetty P, Moiydai A, Gupta T
Implications of limited exolaryngeal disease and cricoarytenoid joint involvement in organ conservation protocols for laryngopharyngeal cancers: Results from a prospective study. Head Neck. 43(4):1289-1299. PMID: 33368793Sinha S, Agarwal JP, Mahajan A, Chaturvedi P, Balaji A, Juvekar S, Gupta T, Budrukkar A, Murthy V, Mummudi N, Swain M, Jadhav R, Laskar SG
Concurrent chemoradiotherapy for locally advanced unresectable adenoid cystic carcinoma of head and neck: experience from a single institute. European archives of oto-rhino-laryngologyl. 278(11):4423-4431 PMID: 33564909Swain M, Ghosh-Laskar S, Budrukkar A, Patil R, Murthy V, Gupta T, Mummudi N, Prabhash K, Joshi A, Patil VM, Naronha V, Agarwal JP
Diagnostic performance of pre-treatment 18F-fluoro-deoxy-glucose positron emission tomography with or without computed tomography in patients with primary central nervous system lymphoma: updated systematic review and diagnostic test accuracy meta-analyses. Clinical Lymphoma Myeloma and Leukemia. 21(8):497-507. PMID: 33947632Gupta T, Manjali J, Kannan S, Purandare N, Rangarajan V
Downregulation of ARID1B, a tumor-suppressor in the WNT subgroup medulloblastoma, activates multiple oncogenic signaling pathways. Human Molecular Genetics. 30(18):1721-1733. PMID: 33949667Deogharkar A, Singh SV, Bharambe HS, Paul R, Moiyadi A, Goel A, Shetty P, Sridhar E, Gupta T, Jalali R, Goel N, Gadewal N, Muthukumar S, Shirsat NV
Prognostic significance of 18F-FDG PET/CT parameters in IDH-1 wild-type GBM and correlation with molecular markers. Nuclear Medicine Communications. 11: 1233-1238. PMID: 34075008Dev ID, Puranik AD, Purandare NC, Gupta T, Sridhar E, Shetty P, Moiyadi A, Agrawal A, Shah S, Rangarajan V
Systematic review and meta-analysis of randomised controlled trials testing the safety and efficacy of convalescent plasma in the treatment of coronavirus disease 2019 (COVID-19): Evidence-base for practise and implications for research. Transfusion Medicine. 31(6):409-420. PMID: 34189780Gupta T, Kannan S, Kalra B, Thakkar P
Upfront therapy of aggressive/high-risk low-grade glioma: single institution outcome analysis of temozolomide-based radio-chemotherapy and adjuvant chemotherapy. World Neurosurgery.154: e176-e184 PMID: 34245877Anand S, Chatterjee A, Gupta T, Panda P, Moiyadi A, Epari S, Patil V, Krishnatry R, Goda JS, Jalali R
MiR-592 activates the mTOR kinase, ERK1/ERK2 kinase signaling and imparts neuronal differentiation signature characteristic of group 4 medulloblastoma. Human Molecular Genetics. 30(24):2524-2525. PMID: 34274968.Paul R, Bapat P, Deogharkar A, Kazi S, Singh SKV, Gupta T, Jalali R, Sridhar E, Moiyadi A, Shetty P, Shirsat NV
Correlation between imaging and tissue biomarkers of hypoxia in squamous cell cancer of the head and neck. World Journal of Nuclear Medidicine. 20(3): 228-236.PMID: 34703390Kunder S, Chatterjee A, Manna S, Mahimkar M, Patil A, Rangarajan V, Budrukkar A, Agarwal J, Gupta T
Biomarkers of Systemic Inflammation in Patients with Glioblastoma: An Analysis of Correlation with Tumour-Related Factors and Survival. Neurology India. 69(4):894-901. PMID: 34507408Madhugiri VS, Subeikshanan V, Dutt A, Moiyadi A, Epari S, Shetty P, Gupta T, Jalali R, Dutt AK
Bone marrow biopsy in PCNSL: Relevant or redundant? Neuro Oncology. 23(12):2117-2118. PMID: 34596688.Gupta T, Manjali JJ, Purandare N, Bagal B
Diagnosis and management of central nervous system embryonal tumors in the molecular era: A contemporary review. International Journal of Neurooncology.4(Suppl S1):190-20Santosh V, Rao S, Dasgupta A, Gupta T
Radiation necrosis of the bone, cartilage or cervical soft-tissues following definitive high-precision radio(chemo)therapy for head-neck cancer: uncommon and under-reported phenomenon. Journal of Laryngology and Otology. PMID: 34823635Gupta T, Maheshwari G, Gudi S, Chatterjee A, Phurailatpam R, Prabhash K, Budrukkar A, Ghosh-Laskar S, Agarwal P
Pilot testing and vernacular translation of a questionnaire for assessment of satisfaction in patients on radiotherapy in India. Indian Journal of Cancer. 58(4): 573-582. PMID: 33402589Manjali JJ, Gupta T, Ghosh-Laskar S, Jalali R, Sarin R, Agarwal JP
- 2020Hippocampal radiotherapy dose-constraints for predicting long-term neurocognitive outcomes: Mature data from a prospective trial in young patients with brain tumors. Neuro-Oncology
Goda JS, Dutta D, Krishna U, Goswami S, Gupta T, Kothavade V, Kannan S, Maitre M, Bano N, Jalali R
Extended adjuvant temozolomide in newly-diagnosed glioblastoma: is more less? Neuro-OncologyGupta T, Chatterjee A, Patil V
A randomized trial of Stereotactic vs. Conventional radiotherapy in young patients with low grade brain tumors: Occupational therapy based neurocognitive data. Neuro-Oncology Advances. 2(1): vdaa130Chatterjee A, Goda JS, Gupta T, Kamble R, Mokal S, Krishnatry R, Sarin R, Jalali R
Resource-sparing curative-intent hypofractionated-accelerated radiotherapy in head and neck cancer: More relevant than ever before in the COVID era. Oral Oncology. 111: 105045. PMID: 33091846Gupta T, Ghosh-Laskar S, Agarwal JP
Extent of re-excision, sequence/timing of salvage re-irradiation, and disease-free interval impact upon clinical outcomes in recurrent/progressive ependymoma. Journal of Neuro-Oncology. 147(2):405-4 PMID: 3207244Gupta T, Maitre M, Gupta P, Krishanty R, Chatterjee A, Moiyadi AV, Shetty P, Singh V, Chinnaswamy G, Epari S, Sahay A, Patil V, Goda JS
Intensity-modulated radiation therapy versus three-dimensional conformal radiotherapy in head and neck squamous cell carcinoma: long-term and mature outcomes of a prospective randomized trial. Radiation Oncology. 15: 218. PMID: 32938468Gupta T, Sinha S, Ghosh-Laskar S, Budrukkar A, Mummudi N, Swain M, Phurailatpam R, Prabhash K, Agarwal JP
Modern radiation therapy for pituitary adenoma: Review of techniques and outcomes. Neurology India 68, Suppl S1:113-22. PMID: 32611901Gupta T, Chatterjee A
ISNO position statement on treatment guidance in neuro-oncology during pandemics. Neurology India. 68(4): 769-773. PMID: 32859812Gupta T, Singh V, Balsubramian A, Menon H, Kurkure P, Kumar S, Jalali R
Diagnostic yield of extensive systemic staging including whole-body 18F-fluoro-deoxy-glucose positron emission tomography with or without computed tomography in patients with primary central nervous system lymphoma: systematic review and meta-analysis. Clinical Lymphoma Myeloma and Leukemia. 20(11): e836-e845. PMID: 32712087Gupta T, Manjali J, Kannan S, Purandare N, Rangarjan V
Optimal adjuvant therapy in elderly glioblastoma: results from a systematic review and network meta-analysis. Journal of Neurooncology. 146(2): 311-320. PMID: 31894517Kalra B, Kannan S, Gupta T
Critical appraisal of a clinical research paper: What one needs to know. Cancer Research, Statistics, and Treatment. 3(3): 545-551Manjali J, Gupta T
Effect of a Structured Teaching Module Including Intensive Prophylactic Measures on Reducing the Incidence of Capecitabine-Induced Hand-Foot Syndrome: Results of a Prospective Randomized Phase III Study. Oncologist. 25(12): e1886-e1892. PMID: 32717127Ostwal V, Kapoor A, Mandavkar S, Chavan N, Gupta T, Mirani J, Saklani A, Desouza A, Shrinivasan K, Nashikkar C, Gupta S, Ramaswamy A
Reverse swing-M, phase 1 study of repurposing mebendazole in recurrent high-grade glioma. Cancer Medicine. 9(13):4676-4685. PMID: 32400117Patil VM, Bhelekar A, Menon N, Bhattacharjee A, Simha V, Abhinav R, Abhyankar A, Sridhar E, Mahajan A, Puranik AD, Purandare N, Janu A, Ahuja A, Krishnatry R, Gupta T, Jalali R
Differentiating dural metastases from meningioma: Role of 68Ga DOTA-NOC PET/CT. Nuclear Medicine Communication. 41(4):356-362. 2020. PMID: 31939900Purandare NC, Puranik A, Shah S, Agrawal A, Gupta T, Moiyadi A, Shetty P, Shridhar E, Patil V, Rangarajan V
Melanotic schwannoma, a deceptive misnomer for a tumor with relative aggressive behavior: A series of 7 cranial and spinal Cases. International Journal of Surgical Pathology. 28(8):850-858 PMID: 32456496Sahay A, Epari S, Gupta P, Goda J, Shetty P, Patil V, Bajpai J, Moiyadi A, Gupta T
Tumor radiomic features complement clinico-radiological factors in predicting long-term local control and laryngectomy free survival in locally advanced laryngo-pharyngeal cancers. British Journal of Radiology. 93(1109): 20190857. PMID: 32101463Agarwal JP, Sinha S, Goda JS, Joshi K, Mhatre R, Kannan S, Laskar SG, Gupta T, Murthy V, Budrukkar A, Mummudi N, Ganeshan B